首页> 外文期刊>ASAIO journal >A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions.
【24h】

A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions.

机译:老年血液透析患者的丙烯腈-共-甲基烯丙基磺酸盐和聚砜膜的交叉研究:对血液动力学,营养和炎症状况的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Many maintenance hemodialysis (MHD) patients have recently been treated with high flux (HF) dialysis membranes such as polysulfone (PSu) membranes. However, the appropriateness of HF for elderly MHD remains to be elucidated. In order to estimate hemodialysis (HD) efficiency, the hemodynamic condition during HD, and the nutritional status, 28 elderly MHD patients were treated with PSu for 3 months. After this, the patients were switched to acrylonitrile-co-methallyl sulfonate (AN69) membranes for the next 3 months and then returned to PSu for another 3 months. Reduction ratio of inflammatory cytokines (interleukin [IL]-6) by AN69 was significantly higher than the reduction ratio by PSu. After 3 months with AN69, the serum total protein, albumin, and cholesterol levels significantly increased, and after switching back to PSu, the levels returned to baseline. Furthermore, the frequency of saline used to treat episodes of hypotension during HD significantly decreased in the AN69 period. In elderly MHD patients, it was possible to achieve improvements in both malnutrition and chronic inflammatory conditions with AN69. This suggests that AN69 may be the preferred membrane for elderly MHD, because it stabilizes the hemodynamic condition and demonstrates a higher removal of inflammatory cytokines during HD.
机译:最近,许多维持性血液透析(MHD)患者已经接受了高通量(HF)透析膜,例如聚砜(PSu)膜的治疗。然而,HF对于老年MHD的适用性仍有待阐明。为了评估血液透析(HD)的效率,HD期间的血液动力学状况以及营养状况,对28例MHD老年患者进行了PSu治疗3个月。此后,在接下来的3个月中,将患者换用丙烯腈-共-甲基烯丙基磺酸盐(AN69)膜,然后再将其返回到PSu中进行3个月。 AN69对炎性细胞因子(白介素[IL] -6)的还原率显着高于PSu的还原率。用AN69治疗3个月后,血清总蛋白,白蛋白和胆固醇水平显着增加,并在切换回PSu后,水平恢复至基线。此外,在AN69期间,用于治疗HD期间低血压发作的生理盐水的频率显着降低。在老年MHD患者中,使用AN69可以改善营养不良和慢性炎症。这表明AN69可能是老年人MHD的首选膜,因为它可以稳定血液动力学状况并显示出HD期间炎性细胞因子的更高去除率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号